Biomarker reagent used for detecting breast cancer state
A biomarker, breast cancer technology, applied in the direction of testing material hardness, measuring devices, instruments, etc., can solve the problems of recurrence and metastasis, high fatality rate, poor prognosis, etc., and achieve the effect of accurate prediction
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0018] 1.1 Materials: Human breast cancer cell lines MDA-MB-231 and MDA-MB-453 were purchased from the American Cell Collection Center (ATCC), and preserved and cultivated by our laboratory; D-MEM medium dry powder, calf serum, trypsin The powder was purchased from Gibco; standard protein molecular weight, SDS-PAGE loading buffer, RIPA protein lysate, TE electrophoresis buffer, 10× transfer solution, 30% Acry-Bis, Tris-Hcl, ammonium persulfate (AP) , SDS, tetramethylethylenediamine (TEMED), and propidium iodide (PI) were purchased from Jiangsu Beyantian Biotechnology Research Institute; dimethyl sulfoxide (DMSO), agarose, and Tween-20 were purchased from Shanghai High-Tech Biology Engineering Co., Ltd.; anti-UHRF1, cyclin B1, cyclin D1 and other antibodies were purchased from Santa Cruzs Biotechnology Company, USA. RNase A and 10 μg / mL proteinase K were purchased from Sigma Aldrich, USA.
[0019] 1.2 Cell culture: MDA-MB-231 and MDA-MB-453 cells were cultured in D-EME medium ...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com